• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ECOG, ACRIN Join Forces

Article

The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) today unveiled their clinical research alliance: ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) today unveiled their clinical research alliance: ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). 

“We are already actively engaged in the shared mission of reshaping the future of patient care through clinical research that leads to earlier cancer detection, more successful therapeutic intervention, greater rates of prevention, and more successful patient outcomes,” officials of the alliance said at the 2011 ACRIN Annual Meeting on Friday. They said their two respective National Cancer Institute cooperative groups have merged their oncology research activities into three core areas of emphasis:

• Early detection and diagnosis of cancer;

• Biomarker-driven Phase II and Phase III therapeutic studies for multiple cancer types and stages; and

• Genetic, molecular and imaging marker research to predict and monitor treatment response.

The organizations seek “bold integration of disciplines and technologies,” with an eye toward conducting “definitive, groundbreaking, biomarker-driven clinical research that promises to achieve patient-centered breakthroughs.”

Integration efforts are afoot and the group’s leadership is developing the business, administrative, and scientific framework for ECOG-ACRIN to sustain and streamline its combined research portfolio through public and private support, ECOG-ACRIN officials said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.